Dr. Shruti K. Gohil, a board-certified UCI Health specialist in infectious diseases, is the associate medical director for UCI Health Epidemiology and Infection Prevention. Her clinical interests include hospital epidemiology, infection prevention, communicable disease transmission and multidrug resistant organism infections.
She led the UCI Health response to the novel coronavirus pandemic, including the clinical and epidemiologic assessment of healthcare providers and patients, COVID-19 testing and vaccination, exposure definition and response, contact tracing, vaccination and infection prevention strategies to limit viral spread.
Gohil earned her medical degree and a master's in public health from Tufts University School of Medicine in Boston, Mass. She completed an internal medicine residency at the UC Davis School of Medicine, followed by a clinical and research fellowship in infectious diseases at the Albert Einstein School of Medicine and Montefiore Medical Center in New York City.
The author or co-author of more than a dozen peer-reviewed publications, Gohil has focused her research on understanding what puts individuals and populations at risk for infectious diseases and ways to mitigate that risk as quickly as possible. This includes devising innovative ways to evaluate, detect and intervene in the spread of healthcare-associated infections. Her novel scoring system, which standardized how central lines are assessed, changed clinical responses and dramatically reduced infection risk at participating hospitals, clinical facilities and nursing homes. She also has led statewide population studies to help reduce the risk of infection-related hospital readmissions and sepsis.
She currently leads several national studies to assess patient risk for multidrug-resistant bacterial infections and to prompt physicians to limit the use of extended-spectrum antibacterial drugs in real time. These include the INSPIRE Demonstration Project, which was recently accepted by the National Institutes of Health Pragmatic Trials Collaboratory, a portfolio of large-scale clinical trials embedded in U.S. healthcare systems. Two randomized INSPIRE clinical trials now underway aim to improve antibiotic prescribing for patients who are hospitalized with abdominal or skin and soft-tissue infections.